{"id":"https://openalex.org/W2070622104","doi":"https://doi.org/10.1007/s002130050062","title":"Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression","display_name":"Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression","publication_year":2000,"publication_date":"2000-03-13","ids":{"openalex":"https://openalex.org/W2070622104","doi":"https://doi.org/10.1007/s002130050062","mag":"2070622104","pmid":"https://pubmed.ncbi.nlm.nih.gov/10928306"},"language":"en","primary_location":{"id":"doi:10.1007/s002130050062","doi":"https://doi.org/10.1007/s002130050062","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002130050062","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010205978","display_name":"Michael J Gitlin","orcid":"https://orcid.org/0000-0001-7236-9649","observed_orcids":["https://orcid.org/0000-0001-7236-9649"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Gitlin","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 90095-6968, USA. mgitlin@mednet.ucla.edu","Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 90095-6968, USA. mgitlin@mednet.ucla.edu","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067023244","display_name":"Keith H. Nuechterlein","orcid":"https://orcid.org/0000-0002-8179-8952","observed_orcids":["https://orcid.org/0000-0002-8179-8952"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. H. Nuechterlein","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Mintz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Mintz","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038313914","display_name":"David L. Fogelson","orcid":"https://orcid.org/0000-0003-0510-8160","observed_orcids":["https://orcid.org/0000-0003-0510-8160"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Fogelson","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073660758","display_name":"George Bartzokis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Bartzokis","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014176970","display_name":"Joseph Ventura","orcid":"https://orcid.org/0000-0002-9242-7903","observed_orcids":["https://orcid.org/0000-0002-9242-7903"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Ventura","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048077014","display_name":"Kenneth L. Subotnik","orcid":"https://orcid.org/0000-0003-0587-7285","observed_orcids":["https://orcid.org/0000-0003-0587-7285"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Subotnik","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072706012","display_name":"Manickam Aravagiri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Aravagiri","raw_affiliation_strings":["Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 300 Medical Plaza, Los Angeles, CA 90095-6968, USA, US","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.4204,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.6554277,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"148","issue":"4","first_page":"350","last_page":"354"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/fluphenazine-decanoate","display_name":"fluphenazine decanoate","score":0.9860000014305115},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.5640000104904175},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/recent-onset-schizophrenia","display_name":"recent-onset schizophrenia","score":0.8479999899864197},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.921999990940094},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.6819999814033508},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8880000114440918},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8159999847412109},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8600000143051147},{"id":"https://openalex.org/keywords/psychosocial-functioning","display_name":"psychosocial functioning","score":0.8370000123977661},{"id":"https://openalex.org/keywords/injectable-antipsychotics","display_name":"injectable antipsychotics","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.9715897440910339},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.7051316499710083},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7039781212806702},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5614324808120728},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5050802826881409},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5008618831634521},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.49572741985321045},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3994407653808594},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3904762864112854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29816576838493347},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005476","descriptor_name":"Fluphenazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005476","descriptor_name":"Fluphenazine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005476","descriptor_name":"Fluphenazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007206","descriptor_name":"Individuality","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012919","descriptor_name":"Social Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s002130050062","doi":"https://doi.org/10.1007/s002130050062","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002130050062","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:10928306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10928306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G76187835","display_name":null,"funder_award_id":"MH 30911","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G7833197143","display_name":"Developmental Processes in Schizophrenic Disorders","funder_award_id":"R01MH037705","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W72235391","https://openalex.org/W86963519","https://openalex.org/W1964565182","https://openalex.org/W1975034617","https://openalex.org/W2008701001","https://openalex.org/W2014595436","https://openalex.org/W2019144775","https://openalex.org/W2020844317","https://openalex.org/W2025745167","https://openalex.org/W2042694515","https://openalex.org/W2049165791","https://openalex.org/W2065205656","https://openalex.org/W2077822166","https://openalex.org/W2089868642","https://openalex.org/W2090504509","https://openalex.org/W2146185589","https://openalex.org/W2398380353","https://openalex.org/W2415650008","https://openalex.org/W2471348333","https://openalex.org/W2901319755"],"related_works":["https://openalex.org/W2162153263","https://openalex.org/W2025745167","https://openalex.org/W4299354298","https://openalex.org/W2072424935","https://openalex.org/W2019138776","https://openalex.org/W2023112061","https://openalex.org/W2415650008","https://openalex.org/W2023590406","https://openalex.org/W2400204632","https://openalex.org/W2416886199"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}